Adobe's AI-driven future is promising, yet valuation and legal risks mean waiting for a short-term pullback to create a good entry point. More
Articles
Why is Immuneering (IMRX) Stock Up 24% Today?
Up nearly 25% in today's session on a fast track designation for a key pancreatic cancer drug candidate, IMRX stock is coming into focus. More
CROX Stock Is Falling Despite a Strong Q2. What’s Causing the Footwear Fumbles?
CROX stock is falling lower after the foam clogs company reported its second-quarter earnings with weak EPS guidance for the third quarter. More
CrowdStrike Technical Analysis: CRWD Stock’s 40% Tumble Reveals Entry Point
CrowdStrike technical analysis points to a potential rebound in CRWD stock as prices approach the golden ratio of around $200 per share. More
“Everyone Knows” AGI Is Coming… but How to Prepare?
Everyone correctly knows that AI is here to stay and that artificial general intelligence (AGI) is coming. But few know the best way to survive... and even thrive... from this increasingly intelligent technology. More
What Are the Hottest Weight Loss Stocks Right Now? 3 Top Picks.
Anti-obesity therapeutics are all the rage and for good reason. Investors seeking to profit should consider these weight loss stocks. More
3 Small-Cap Stock Picks With Little or No Debt
Small-cap stocks are one thing. Small-cap stocks with low debt are another thing entirely. Here are three worthy of consideration. More
